Atlas Trials

Efficacy of Tocilizumab on Patients With COVID-19

Clinical trial NCT04356937 · COMPLETED

Trial details

NCT number
NCT04356937
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-CoV 2
Start date
2020-04-20
Primary completion
2020-07-13
Enrollment
243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.